Tom Flaherty currently serves as the Executive Director of Cardiac Solutions at Clario, focusing on cardiovascular safety for North America biotech since August 2025. Prior to this role, Flaherty held several strategic positions in the healthcare and biotech sectors, including Director of Sales for Cardiac Digital Solutions at AliveCor, and Client Partner for Digital Biomarkers at Verily, a subsidiary of Alphabet. Flaherty's experience also includes senior roles at Signant Health, Philips, Kantar Health, WCG MedAvante-ProPhase, and PPS, where Tom specialized in clinical trials and strategic partnerships, particularly in cardiac safety and digital health innovations. Flaherty began the professional journey at GSK as an Executive Therapeutic Specialist in Cardiology after earning a marketing degree from Saint Joseph's University.
This person is not in any teams
This person is not in any offices